NewAmsterdam Pharma Co. NV (NAMS)
29.78
+1.16
(+4.04%)
USD |
NASDAQ |
Mar 16, 16:00
29.78
0.00 (0.00%)
After-Hours: 20:00
NewAmsterdam Pharma Shareholders Equity (Quarterly) : 683.43M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| uniQure NV | 198.90M |
| ProQR Therapeutics NV | 57.99M |
| argenx SE | -- |
| Pharming Group NV | 277.10M |
| Pharvaris NV | 366.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 769.28M |
| Total Liabilities (Quarterly) | 85.85M |
| Debt to Equity Ratio | 0.0003 |
| Current Ratio | 7.876 |
| Net Debt Paydown Yield | 0.00% |